Japan
Clifford Chance has advised Japan’s Suntory Beverage & Food Ltd. on its $2.1 billion purchase of two beverage brands—Lucozade and Ribena—from British pharmaceutical giant GlaxoSmithKline Plc. Pending regulatory approval, the deal is expected to close by the end of the year. London partners Joel Ziff and Robert Crothers are leading the Clifford Chance team advising Suntory. Allen & Overy is acting for GSK, with its team led by London partners Ed Barnett and Andrew Ballheimer. [Read full story]
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
